- Home
- IRON vs TTMI Comparison
IRON vs TTMI Comparison
Compare IRON & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- TTMI
- Stock Information
- Founded
- IRON 2017
- TTMI 1978
- Country
- IRON United States
- TTMI United States
- Employees
- IRON N/A
- TTMI N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- TTMI Electrical Products
- Sector
- IRON Health Care
- TTMI Technology
- Exchange
- IRON Nasdaq
- TTMI Nasdaq
- Market Cap
- IRON 1.9B
- TTMI 1.9B
- IPO Year
- IRON N/A
- TTMI 2000
- Fundamental
- Price
- IRON $42.17
- TTMI $18.65
- Analyst Decision
- IRON Strong Buy
- TTMI Strong Buy
- Analyst Count
- IRON 10
- TTMI 5
- Target Price
- IRON $83.80
- TTMI $28.25
- AVG Volume (30 Days)
- IRON 608.5K
- TTMI 736.4K
- Earning Date
- IRON 05-08-2025
- TTMI 04-30-2025
- Dividend Yield
- IRON N/A
- TTMI N/A
- EPS Growth
- IRON N/A
- TTMI N/A
- EPS
- IRON N/A
- TTMI 0.54
- Revenue
- IRON N/A
- TTMI $2,442,753,000.00
- Revenue This Year
- IRON N/A
- TTMI $8.03
- Revenue Next Year
- IRON N/A
- TTMI $4.43
- P/E Ratio
- IRON N/A
- TTMI $34.54
- Revenue Growth
- IRON N/A
- TTMI 9.41
- 52 Week Low
- IRON $25.64
- TTMI $13.43
- 52 Week High
- IRON $68.73
- TTMI $30.41
- Technical
- Relative Strength Index (RSI)
- IRON 42.98
- TTMI 37.90
- Support Level
- IRON $39.20
- TTMI $18.23
- Resistance Level
- IRON $41.41
- TTMI $19.52
- Average True Range (ATR)
- IRON 4.37
- TTMI 1.21
- MACD
- IRON 0.09
- TTMI 0.04
- Stochastic Oscillator
- IRON 54.14
- TTMI 53.33
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. It organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.